Lexicon Pharmaceuticals, Inc.

Healthcare · Biotechnology · United States

Last price 1.48 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 658.53M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. The company develops sotagliflozin, an orally-delivered small molecule drug for the treatment of hypertrophic cardiomyopathy, and ZYNQUISTA (sotagliflozin) for the treatment of type 1 diabetes. It also commercializes INPEFA (sotagliflozin), a once-daily oral tablet to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart fail...